3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting researcher scrutiny due to initial data suggesting different physiological characteristics. Preliminary analyses suggest that 3-HPC may exhibit distinct impacts on the nervous structure, arguably contributing to some of the unexpected reactions related w